The endogenous circadian rhythm of melatonin, driven by the suprachiasmatic nucleus, exhibits a close association with the endogenous circadian component of the sleep propensity rhythm and the endogenous circadian component of the variation in electroencephalogram (EEG) oscillations such as sleep spindles and slow waves. This association is maintained even when the sleep-wake cycle is desynchronized from the endogenous circadian rhythm of melatonin. Administration of melatonin during the day increases daytime sleep propensity as indexed by both the latency to sleep onset and sleep consolidation. The EEG during daytime sleep after melatonin administration exhibits characteristics reminiscent of the nocturnal sleep EEG, that is, increased sleep spindle activity and reduced slow-wave sleep and slow-wave activity as detected by quantitative EEG analysis. Administration of higher doses of melatonin (5 mg or more) prior to nocturnal sleep results in an increase in rapid eye movement (REM) sleep. These data demonstrate that melatonin exerts effects on the main characteristics of human sleep, that is, latency to sleep onset, sleep consolidation, slow waves, sleep spindles, an M sleep. There is a need for further studies using physioloRical doses and delivery systems that generate physiological plasma melatonin profiles to firmly establish the role of the endogenous circadian rhythm of melatonin in the circadian regulation of sleep.
Introduction
An ideal hypnotic may be thought of as a substance that interferes with physiological sleep regulatory mechanisms and effectively induces physiological sleep during both short-term and long-term use. This notion implies that an essential part of the evaluation of melatonin as an effective hypnotic is an assessment of the role of melatonin in the physiological regulation of sleep. Such an assessment is facilitated by explicit physiological models of sleep regulation and experimental protocols derived from these models. In view of the intimate link between melatonin and the endogenous circadian timing system and the pivotal role of the circadian pacemaker in the regulation of sleep, it seems reasonable to evaluate melatonin within the context of the circadian aspect of sleep regulation.
Aspects of sleep for which the circadian contribution has been studied include sleep initiation, sleep consolidation, sleep structure, and the sleep electroencephalogram (EEG) . For each of these sleep parameters, we first briefly outline the current knowledge about its circadian regulation as derived from a variety of experimental protocols. Next, for each of these sleep parameters, we discuss the temporal relationship with the circadian rhythm of melatonin. Finally, we discuss the effects of melatonin administration on these sleep parameters.
Melatonin and the Circadian Regulation of Sleep: General Considerations
The circadian aspect of sleep regulation is distinct from the homeostatic or sleep-wake dependent aspects of sleep regulation. For instance, the increase in sleep propensity and slow-wave oscillations in the EEG during non-rapid eye movement (REM) sleep as observed after extended wakefulness is attributed to the homeostatic aspect, whereas the reduction in sleep propensity in the evening hours (the so-called wake maintenance zone) that is observed even when people have been awake for 14 h or more, as well as the rapid increase in sleep propensity that follows the wake maintenance zone, are attributed to circadian aspects of sleep regulation.
Early insights in the circadian regulation of sleep were derived from experiments in which subjects could self-select their sleep-wake cycles and associated light-dark cycles while living in environments without time cues. More recently, the circadian aspect has been quantified in protocols in which sleep is scheduled to occur at all different circadian phases, while the variation in the duration of wakefulness preceding sleep (i.e., variation in the homeostatic aspect) is minimized. Protocols that allow for such an appraisal include ultra-short sleep-wake studies in which subjects have the opportunity to sleep 7 out of every 20 min, 90-min day studies in which subjects can sleep 30 out of every 90 min, and forced desynchrony protocols in which the sleep-wake cycle is either shorter than 24 h (e.g., 20 h) or longer than 24 h (e.g., 28 h) and subjects are scheduled to sleep for one third of the period of the sleep-wake cycle (e.g., 6.7 and 9.3 h for the 20-and 28-h days, respectively) (for references, see Dijk and Czeisler, 1995) .
Accurate assessment of the circadian variation in sleep parameters requires polysomnographic record-ings, although alternative methods such as actigraphy, or assessment of subjective sleep quality, also may be useful. In addition, it is pertinent that reliable information on endogenous circadian phase be obtained in these protocols. If, in this context, a variable such as melatonin or body temperature is used primarily as a phase marker of the endogenous circadian pacemaker, then it is vital to control for the so-called masking effects such as those exerted by light, posture, and activity. The implicit assumption in this approach is that it is not the variable itself (e.g., melatonin, body temperature) that is related to the circadian variation of a sleep parameter, but this circadian variation is related to some other unknown rhythmic output of the circadian pacemaker. This unknown rhythmic output is assumed to maintain a fixed-phase relationship to the phase marker (e.g., melatonin).
If, on the other hand, it is assumed that the variable itself is involved in the circadian regulation of sleep (the variable is part of the output pathways by which the circadian pacemaker modulates sleep [i.e., the variable can be considered an endogenous circadian hypnotic signal]), then it is important that the measurements of the variable and the assessment of sleep be done under identical conditions. For instance, the timing of dim light melatonin onset (DLMO) (as assessed in dim light) does not necessarily provide information on the role of melatonin itself in sleep initiation under entrained conditions because, under entrained conditions, subjects will be exposed to light of sufficient intensity to at least partially suppress melatonin. The assessment of DLMO may, however, provide some information on the phase relationship between the circadian pacemaker and habitual timing of sleep under entrained conditions. The aforementioned protocols and methods have generated an estimate of the circadian contribution to some or all of the characteristics of sleep listed in what follows. In most of the experiments, body temperature has served as the primary circadian phase marker, although there is now a growing number of reports in which information on the rhythm of plasma melatonin also is available. To the best of our knowledge, in none of the published reports in which both melatonin and body temperature have been analyzed has a major dissociation between the rhythm of melatonin and the circadian rhythm of temperature been reported, although some intra-and intersubject variability in their phase relationship may exist.
Sleep Initiation

Circadian Modulation
This parameter (i.e., the propensity to fall asleep) is easy to assess. The main requirements are a test of sufficient duration (i.e., the interval during which the subject attempts to fall asleep should be at least 20 min long), a sufficient high resolution across the circadian cycle, and a similar homeostatic sleep pressure at the beginning of each test.
The circadian contribution to sleep initiation has been well characterized, and the consensus emerging from the aforementioned protocols is that the circadian drive for sleep is lowest at that circadian phase at which the unmasked endogenous circadian temperature rhythm reaches its crest. Constant routine studies carried out immediately on release from entrainment have demonstrated that in young subjects the body temperature crest is located in the evening between 2000 and 2200 h, or approximately 2 to 3 h before habitual bedtime (Krduchi and Wirz-Justice, 1994). After this nadir in sleep propensity, there is a sudden and rapid increase in the ability to fall asleep (Lavie, 1986; Dijk and Czeisler, 1994) . This has been referred to as the opening of the sleep gate or the dissipation of the circadian drive for wakefulness. Forced desynchrony protocols have demonstrated that after the opening of the sleep gate, there is a further, albeit small, increase in the ability to fall asleep (Dijk and Czeisler, 1994) . The crest of the endogenous circadian rhythm in the ability to initiate sleep is located close to the nadir of the core body temperature rhythm, which, under entrained conditions in healthy young subjects, occurs at on average 0554 h (SD = 1.30), which is on average 2.38 h (SD = 1.16) before habitual wake time (Duffy et al., 1997) . Following the nadir of the core body temperature rhythm, the ability to fall asleep gradually declines until it reaches its evening low. In some (but not all) protocols, an increase in the ability to fall asleep has been observed approximately 10 to 14 h after the temperature minimum (Lack and Lushington, 1996) . However, the magnitude of this mid-aftemoon increase in the ability to fall asleep is much smaller than the nocturnal increase in sleep propensity Association with Rhythm of Melatonin In sighted volunteers living in society, the onset of the nocturnal melatonin secretion occurs approximately 2 h before habitual bedtime (Tzischinsky et al., 1993) . In blind people in whom the circadian pacemaker is not entrained (Nakagawa et al., 1992) , and in a sighted subject with non-24-h sleep-wake cycle syndrome (McArthur et al., 1996) , a tight association between the propensity to initiate sleep (as assessed in the ultra-short sleep-wake paradigm) and the phase of melatonin secretion has been described.
Effect of Exogenous Melatonin
Relevant parameters of protocols in which the effects of exogenous melatonin on sleep initiation are investigated are clocktime/circadian phase of melatonin administration, clocktime/circadian phase of sleep propensity assessment, homeostatic drive for sleep during sleep propensity assessment, and dose of melatonin. In young subjects without sleep complaints, studies in which melatonin was administered during the daytime (i.e., when endogenous levels of melatonin are low) and sleep initiation also was assessed during the daytime (i.e., the interval between melatonin administration and assessment was relatively short) have shown a dose-dependent (0.3 to 10.0 mg) reduction in sleep latency (Dollins et al., 1994; Tzischinsky and Lavie, 1994; Zhdanova et al., 1996; Reid et al., 1996) .
These effects can be observed throughout the biological day, that is, during the entire phase in which endogenous melatonin levels are low. Clearest results were obtained when endogenous sleep propensity was low (i.e., either under conditions in which the homeostatic drive for sleep was low [Dollins et al., 1994] or the circadian drive for wakefulness was strong (e.g., shortly before or during the wake maintenance zone [Zhdanova et al., 1996]) . No significant effect of melatonin on sleep initiation was observed in those experiments in which the homeostatic drive for sleep was high (Dijk et al., 1995a) . Melatonin (5 mg) administration in the early evening (1800 h) and subsequent assessment of the sleep effects at 2300 h resulted in a small reduction of the already short polysomnographically recorded sleep latencies (Cajochen et al., 1997). Deacon and Arendt (1995) reported a dose-dependent (0.05, 0.5, or 5 mg at 1700 h) reduction in subjectively assessed sleep latency with start of the scheduled sleep episode at 2400 h.
Implications
Given the strong circadian drive for wakefulness in the evening hours (just before the onset of melatonin secretion) and the positive effect of exogenous mela-tonin on the ability to initiate sleep outside the phase of endogenous melatonin secretion, it seems reasonable to conclude that melatonin may play a role in the treatment of sleep onset insomnia related to a mismatch between the endogenous circadian timing system and the preferred clock time for sleep onset such as occurs in delayed sleep phase syndrome. In this condition, there is no conflict between the effects of melatonin on circadian phase and its effects on sleep initiation because the phase advance of the endogenous circadian timing system, as induced by melatonin administration shortly before the preferred bedtime, and the direct hypnotic effect of melatonin both will benefit the rapid onset of sleep.
Sleep Consolidation
Circadian Modulation
Assessment of the circadian regulation of sleep consolidation (i.e., the ability to maintain sleep) requires protocols in which scheduled sleep episodes are of sufficient duration (i.e., close to the duration of nocturnal sleep episodes [7-9 h]) while, at the same time, the requirements of a sufficient temporal resolution across the circadian cycle and a similar homeostatic drive at the onset of all of these sleep episodes are met. Forced desynchrony protocols allow for such an assessment, and these protocols have revealed that the circadian modulation of sleep consolidation after a waking episode of 18 h does not become substantial until sleep pressure has dissipated considerably, that is, until subjects have been asleep for several hours. Comparison of the circadian rhythm of sleep consolidation and the circadian regulation of sleep initiation suggests that a common process underlies both of these rhythms. Thus, the circadian rhythm of sleep consolidation reaches its crest at or shortly after the temperature minimum. Hereafter, sleep consolidation gradually decreases on the rising limb of the body temperature rhythm until it reaches its nadir close to the temperature maximum and then increases very rapidly Czeisler, 1994, 1995) .
Association with Rhythm of Melatonin Very few studies have investigated the association between the endogenous circadian rhythm of plasma melatonin and sleep consolidation. Lockley et al.
(1997) described a correlation between the duration of self-selected daytime naps and the phase of the urinary melatonin rhythm in subjects without conscious light perception. In the majority of these subjects, the urinary melatonin rhythm was free running. The longest naps, as assessed by questionnaires, were observed when melatonin secretion occurred during the daytime.
In a forced desynchrony protocol in which sighted volunteers were scheduled to a 28-h sleep-wake schedule in an approximately 1-month experiment and scheduled sleep episodes were 9 h 20 min long, sleep consolidation exhibited a close association with the endogenous rhythm of melatonin (Fig. 1) (Dijk et al.,1995b) . Sleep consolidation gradually deteriorates during that phase of the endogenous circadian cycle during which melatonin secretion is low. Sleep consolidation improves dramatically as soon as scheduled sleep episodes coincide with the phase of melatonin secretion. This association is remarkable in view of the fact that the sleep episodes were long and therefore homeostatic sleep pressure was at low levels, especially at the end of these sleep episodes. It is interesting that after the offset of melatonin secretion, the change in sleep consolidation is less abrupt than at the onset of the phase of melatonin secretion.
Effect of Exogenous Melatonin
To assess the effects of exogenous melatonin on sleep consolidation, experiments are required in which the duration of this scheduled sleep episode is sufficiently long (7-9 h) and sleep efficiency at baseline is sufficiently low to allow for improvement. These requirements can be met in studies of nocturnal sleep in older people or in studies in which sleep is displaced to an adverse circadian phase (i.e., the daytime hours) in healthy young subjects. The promising effects of melatonin on sleep consolidation are reviewed by Lavie (1997 [this issue] ).
Hughes and Badia (1997) reported improved sleep efficiency during the last hour of a 4-h daytime sleep episode after administration of 1, 10, or 40 mg at 1000 h in young healthy volunteers.
Negative effects on sleep consolidation at the very end of the nocturnal sleep episode (i.e., earlier awakening or earlier sleep offset) have been reported in a protocol in which melatonin (0.05-5 mg) was administered 7 h before habitual bedtime and sleep was assessed by questionnaires (Deacon and Arendt, 1995) . In a polysomnographically controlled study, such an earlier offset of sleep was not observed on the 1st night after administration of 5 mg of melatonin 5 h before habitual bedtime (Cajochen et al., 1997) . Interestingly, Figure 1 . Endogenous circadian rhythm of core body temperature, plasma melatonin, and wakefulness in scheduled sleep episodes during a forced desynchrony protocol. Data were collected in 7 healthy, young male volunteers who were scheduled to a 28-h sleep-wake cycle for approximately 1 month. Plasma melatonin data are expressed as z scores, and wakefulness is expressed as a percentage of electroencephalogram recording time during the 9 h 20 min sleep episodes. Thus, 40% wakefulness corresponds to a sleep efficiency of 60%. SOURCE: Modified from Dijk et al. (1995b) . Reprinted with permission from Elsevier Science. in this study an earlier offset of sleep was observed in the 2nd night after melatonin administration. Because this sleep episode was initiated 29 h after melatonin administration, these effects have been interpreted as reflecting a phase advance of the circadian timing system similar to the effects of bright light exposure in the morning hours.
Recently, Middleton et al. (1996) reported that in a group of subjects who could self-select their sleepwake times while living in a closed, dimly lit facility with knowledge of clock time, administration of melatonin at 2000 h resulted in fragmentation of the sleepwake cycle (as assessed with wrist actigraphy) in 4 out of 16 subjects.
Implications
One potential application of melatonin administration is the treatment of impaired sleep consolidation such as can be observed in night shift workers sleeping during the daytime or older people waking up too early in the morning. Two implications for the way in which melatonin is to be administered in these applications emerge from the analyses of the circadian regulation of sleep consolidation. Because at virtually all circadian phases sleep consolidation is most impaired at the end of sleep episodes, it seems reasonable to develop delivery systems that can maintain high melatonin levels throughout the sleep episode or even preferentially deliver melatonin in the second half of the sleep episode.
Administration of melatonin to improve nocturnal sleep consolidation in older people should not be timed in such a way that it could induce an advance of the circadian timing system, because this will worsen sleep consolidation in the second half of the sleep episode. Therefore, it also may be preferable in this application to make use of a delivery system that can maintain melatonin release throughout the sleep episode or can deliver melatonin in the second half of the sleep episode only Sleep Structure
Circadian Modulation
Assessment of the circadian modulation of sleep structure (i.e., the contribution of REM sleep and non-REM sleep to total sleep time) requires polysomnographic recordings and sleep episodes of sufficient duration. The latter requirement is a consequence of the ultradian regulation of the alternation between non-REM and REM sleep, which in humans has a period of approximately 70 to 90 min.
The impact of the endogenous circadian pacemaker on REM sleep is well known. The crest of the circadian rhythm of REM sleep is located 1 to 2 h after the nadir of the endogenous circadian temperature rhythm and close to the peak of the sleep propensity rhythm. Thus, under entrained conditions, the peak of REM sleep propensity is located at the very end of the sleep episode (Dijk and Czeisler, 1995) . The circadian regulation of REM sleep is primarily related to the duration of REM sleep episodes rather than the latency to REM sleep, which is only slightly affected by circadian phase. Inspection of the circadian wave form of REM sleep propensity suggests that to induce an increase in REM sleep in the initial part of sleep episodes by phase advancing the circadian rhythm of REM sleep, a phase advance of at least 4 to 6 h is needed. This is in accordance with the observation that phase advances of the human circadian pacemaker in the range of 1 to 2 h, as induced by light exposure, result in neither a significant change in REM latency nor a change in the duration of REM sleep (Dijk et al., 1989) .
The circadian regulation of non-REM sleep has been described less frequently than the circadian regulation of REM sleep. The crest of the circadian rhythm of non-REM sleep is located close to the crest of the temperature rhythm (i.e., the low point of sleep propensity), and its nadir coincides with the nadir of the temperature rhythm.
Association with Rhythm of Melatonin The circadian rhythm of REM sleep bears no clear relationship with the circadian rhythm of melatonin. The crest of the REM rhythm is located several hours after the melatonin maximum, 1 to 2 h after the minimum of the body temperature rhythm. However, this does not imply that there is no relationship between the circadian rhythm of melatonin and REM sleep. Such a relationship may exist in view of the close relationship between REM sleep and thermoregulation and the hypothermic effects of melatonin (Cagnacci et al., 1997 [this issue]).
Effect of Exogenous Melatonin
A number of studies have investigated the effects of melatonin on REM sleep. In general, either REM sleep was not affected or an increase was observed. The most striking effects were reported recently after melatonin (5 mg) administration either 5 h before nocturnal sleep (Cajochen et al., 1997) or 3 h before nocturnal sleep (Cajochen, Krduchi, and Wirz-Justice, unpublished data). In these experiments, the first REM episode was markedly lengthened (Fig. 2) . However, this effect no longer was significant in the second sleep episode, which was initiated 29 or 27 h after melatonin administration. These effects are consistent with earlier experiments in which higher doses of melatonin were administered (see references in Zhdanova et al., 1996) . Interestingly, no significant increase in REM sleep was reported during afternoon sleep after melatonin (1, 10, or 40 mg) administration ciated with changes in REM sleep. The effects of melatonin on REM sleep indicate either that there is a very large shift of the circadian pacemaker (which is unlikely in view of the amplitude of the phase response curve for melatonin) or that the effects of melatonin on REM sleep are mediated by other mechanisms such as the lowering of core body temperature. However, the observation that the increase in REM sleep is observed primarily during nocturnal sleep, even though the hypothermic effects of melatonin appear to be present at all circadian phases, is not easy to reconcile with this hypothesis and points to a complex interaction of circadian phase and melatonin's effects on REM sleep regulation.
Sleep EEG
Circadian Modulation
Assessment of the circadian modulation of the EEG during sleep requires quantitative EEG analyses such as those based on the fast Fourier transform. Such analyses, carried out separately for non-REM and REM sleep, have provided considerable evidence that all benzodiazepine hypnotics and the non-ben-zodiazepine hypnotics that bind to the GABAA-benzodiazepine receptor complex reduce EEG activity in the delta and theta range and enhance activity in the frequency range of sleep spindles (12-15 Hz) in non-REM sleep. Until recently, it was not known whether the endogenous circadian pacemaker modulates the EEG during sleep. Application of spectral analysis in forced desynchrony protocols has revealed that the circadian pacemaker exerts a significant influence on the EEG, which suggests that the output pathways of the pacemaker do play a role in EEG activation and deactivation. The circadian variation in the EEG during sleep, first described in relation to the rhythm of core body temperature, affects both slow waves and sleep spindles during non-REM sleep Czeisler, 1995, Dijk et al., 1995b) . The changes in slow waves and sleep spindles are of particular interest because these oscillations are essential correlates of EEG deactivation and some of the neurophysiological mechanisms involved in their genesis have been uncovered. Furthermore, the effects of sleep deprivation (which is accompanied by an increase in sleep propensity) on slow waves and sleep spindles have been described in considerable detail. Slow waves increase and sleep spindles decrease after sleep deprivation (for references, see Dijk and Czeisler, 1995) . The endogenous circadian modulation of slow waves is of low amplitude, but somewhat surprisingly, the crest of this rhythm is located close to the nadir of the sleep propensity rhythm, and its nadir is located close to the peak of the endogenous circadian rhythm of sleep propensity. Sleep spindles exert a marked circadian variation that is specific for non-REM sleep. This variation appears to involve both a variation in the frequency of sleep spindle activity and a variation in total sleep spindle activity. Low-frequency sleep spindle activity crests during the phase of high circadian sleep propensity, whereas high-frequency sleep spindle activity peaks during the circadian phase of low circadian sleep propensity.
Association with Rhythm of Melatonin The low-amplitude circadian modulation of slow waves is closely associated with the endogenous circadian rhythm of melatonin, whereas the endogenous circadian modulation of sleep spindles and their frequency is slightly phase advanced with respect to the melatonin rhythm (Dijk et al., 1995b; Dijk et al., in press ). 
Effect of Exogenous Melatonin
An effect of exogenous melatonin on sleep-stagespecific EEG characteristics was reported by Dijk et al. (1995a) . In this double-blind, placebo-controlled crossover study, daytime sleep after nocturnal sleep curtailment was studied. Quantitative analysis of the EEG using fast Fourier transform revealed that 5 mg of melatonin given shortly before the daytime sleep episode results in a suppression of slow EEG components and an increase in the frequency range of sleep spindles (Fig. 3 ). These effects are short lasting and are of moderate size. The effects of melatonin on sleep-stagespecific EEG spectra during daytime sleep were replicated by Nave and coworkers (1996) , and both research groups pointed out that the effects of melatonin are, to some extent, similar to the changes induced by benzodiazepine hypnotics. Interestingly, the effects of melatonin on EEG spectra could not be blocked by flumazenil, which may indicate that the effects are not mediated by the GABA~ benzodiazepine receptor complex.
The effects of melatonin on slow waves are sufficiently pronounced to be detected by visual scoring. Thus, a significant reduction in visually scored slowwave sleep and an increase in Stage 2 during daytime sleep after 1, 10, or 40 mg was reported by Hughes and Badia (1997) . Such reductions of visually scored slowwave sleep also were present during early nocturnal sleep after administration of low doses of melatonin 1 h before sleep onset, although this effect was not significant (Zhdanova et al., 1996) .
Implications
The effects of melatonin on sleep spindles are small compared to the circadian modulation in the characteristics of sleep spindles, but the effects on slow waves are of a magnitude comparable to the circadian modulation and opposite to the effects of sleep deprivation. The effects of melatonin on the EEG are short lasting and are not observed when melatonin is administered 5 h before sleep onset (Cajochen et al., 1997) . The functional significance of these changes and the receptor mechanisms by which these effects are mediated remain unclear. These effects of melatonin on the EEG are not only observed during sleep. Cajochen and coworkers (1996) demonstrated that 5 mg of melatonin also exerts a profound effect on the EEG during wakefulness.
Concluding Comments
A remarkably tight association between the endogenous circadian rhythm of melatonin and sleep propensity has been described. This observation, as well as the observation that daytime administration of melatonin increases sleep propensity (as indexed by sleep latency and sleep consolidation) and affects the EEG during non-REM sleep, suggests that melatonin has direct effects on sleep regulatory mechanisms and that its circadian modulation may be part of the pathways by which the circadian pacemaker drives the circadian rhythm in sleep propensity and sleep structure. Melatonin's effects on REM sleep during nocturnal sleep, which have been observed 3 to 5 h after melatonin administration, may reflect effects of melatonin on the phase of the circadian pacemaker. Alternatively, these effects of melatonin on REM sleep may be related to the lowering of core body (and brain) temperature, which in turn may affect REM sleep propensity.
Most studies in which effects of melatonin on sleep were described used a dose of 5 mg, which results in pharmacological plasma levels. There is a need for further studies using physiological doses and delivery systems that generate physiological plasma melatonin profiles while at the same time sleep is scheduled at a variety of circadian phases to firmly establish the role of the endogenous circadian rhythm of melatonin in the circadian regulation of sleep.
